Updated:
I-Life Medical Device Technology
I-Life Medical Device Technology is a private equity firm based in Suzhou, China. It focuses on venture capital investments. The firm has a staff of 50.
I-Life Medical Device Technology
I-Life Medical Device Technology is a private equity firm based in Suzhou, China. It focuses on venture capital investments. The firm has a staff of 50.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Suzhou
Corporate office
Suzhou, Jiangsu, China
Sector focus
Frequently asked questions
What investment stages does I-Life Medical Device Technology target?
I-Life focuses on seed-stage and early-stage investments in medical device and digital health companies (per public record). The firm does not disclose follow-on funding or later-stage participation.
Which sectors does I-Life Medical Device Technology explicitly avoid?
I-Life appears to avoid non-healthcare sectors such as fintech, enterprise software, and consumer goods, given its stated focus on medical devices and digital health.
Does I-Life Medical Device Technology participate in fund commitments or only direct deals?
I-Life is structured as a direct investor in portfolio companies, not as a fund-of-funds. It provides equity capital directly to early-stage medical device startups (per public record).
Where does the underlying wealth come from for I-Life Medical Device Technology?
The source of capital for I-Life is not publicly disclosed. The firm does not identify its limited partners or the origin of its investment funds.
How does I-Life Medical Device Technology source proprietary deal flow?
I-Life likely sources deals through its network in Suzhou's medical device industrial ecosystem, though specific sourcing methods are not publicly documented (Altss estimate).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: